[The prognostic value of type-1 myosin heavy chain in the skeletal muscle of patients with chronic heart failure of a mild-moderate degree].
Patients with chronic heart failure (CHF) develop skeletal muscle disease (myopathy) that is in part responsible for the decrease of their exercise tolerance. While maximal oxygen consumption (VO2), metabolic equivalent (MET) and NYHA functional class are good prognostic indices, it is not known whether markers of skeletal muscle myopathy could carry the same meaning. We tested the hypothesis that myosin heavy chain 1 (MHC1) could have a prognostic value in 18 patients with different degree of CHF. Patients were enrolled in January 1995 and followed up for 3 years. At baseline all subjects performed cardiopulmonary exercise test, echocardiography and gastrocnemius needle biopsy for determination of MHC1 percentage. Thereafter patients were divided into two groups (A and B) according to MHC1 percentage (< or = 70 and > 70). The number of cardiovascular events, the time to the first admission to the hospital and the time to death were considered as end points in our study. Eighty-three percent of the events and all deaths happened in Group A. The time of the first admission and the survival curves were worse in Group A (p = 0.008 and p = 0.02 respectively). Similar results were obtained when patients were divided according to VO2 (< or = 18 and > 18 ml/kg/min), MET (< or = 5 and > 5) and NYHA functional class (III/IV and I/II). We also observed a correlation between MHC1, VO2 (r = 0.3, p = 0.01), MET (r = 0.5, p = 0.0006) and NYHA functional class (r = 0.1, p = 0.07). In conclusion, the CHF myopathy, estimated by MHC1 percentage, gives prognostic information similar to VO2, MET and NYHA functional class.